Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. WuXi AppTec Co., Ltd.
  6. Company
    603259   CNE1000031K4

WUXI APPTEC CO., LTD.

(603259)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
WuXi AppTec Co., Ltd. specializes in providing a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical and biotech industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. Net sales break down by activity as follows:

- laboratory services (65,7%): small molecules discovery services, bioanalytical services, medical devices safety testing services, comprehensive manufacturing and testing services for cell and gene therapies, etc.;

- CMO and CDMO services (28.1%): development of manufacturing processes, production of advanced intermediates and active pharmaceutical ingredients, formulation development and dosage drug product manufacturing, for preclinical and clinical trials, new drug application, and commercial supply of chemical drugs, etc.;

- clinical research services (6.1%): project planning, clinical operation and monitoring and managements of phase I-IV clinical trials, medical device trials, etc.;

- other (0.1%).

Net sales are distributed geographically as follows: China (25.4%), Asia (2.9%), the United States (54.6%), Europe (15.8%) and other (1.3%) .

Number of employees : 26 411 people.
Sales per Business
20192020Delta
Laboratory Services in China6 473.2150.4%8 545.8251.8% +32.02%
Small Molecule Drug Development Process and Production3 752.0529.2%5 282.0532% +40.78%
U.S. District Laboratory Services1 562.9312.2%1 516.609.2% -2.96%
Clinical Research and Other Contract Research Organization Services1 062.798.3%1 168.857.1% +9.98%
Other21.220.2%22.100.1% +4.18%
CNY in Million
Sales per region
2020
United States8 861.9153.7%
China4 145.3325.1%
Europe2 650.7816.1%
Other Parts of Asia679.654.1%
Other Regions197.761.2%
Abroad--
CNY in Million
Managers
Name Title Age Since
Min Zhang Chen Co-Chief Executive Officer 51 2021
Qing Yang Co-CEO, Executive Director & Executive VP 51 2020
Ge Li, Dr. Chairman & President 54 -
Ellis Chu Chief Financial Officer & Senior Vice President - -
Frederick Hausheer Chief Medical Officer - 2019
Guo Dong Tong Chief Operating Officer & Senior Vice President - -
Edward Hu Vice Chairman & Chief Investment Officer 57 2020
Jiang Nan Cai, Dr. Independent Non-Executive Director 63 -
Yan Liu Independent Non-Executive Director 47 -
He Tong Lou, Dr. Independent Director 58 2017
Members of the board
Name Title Age Since
Ge Li, Dr. Chairman & President 54 -
Harry He Chairman-Supervisory Board 54 2016
Edward Hu Vice Chairman & Chief Investment Officer 57 2020
Ning Zhao, Dr. Executive Director & Vice President 54 2016
Xiao Zhong Liu Director & Vice President 56 2016
Zhao Hui Zhang Executive Director & Head-Government Affairs 51 2016
Min Fang Zhu Member-Supervisory Board 49 2016
Xiao Meng Tong Non-Executive Director 46 2016
Jiang Nan Cai, Dr. Independent Non-Executive Director 63 -
Yan Liu Independent Non-Executive Director 47 -
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,563,493,617 1,723,471,445 67.2% 0 0.0% 58.3%
Stock B 0 391,934,191 0 0.0% 0 0.0%
Shareholders
NameEquities%
Ge Li 740,070,220 29.1%
Pavilion Capital Pte Ltd. 159,160,073 6.25%
Shanghai Zhongmin Yinfu Capital Management Co. Ltd. 116,098,013 4.56%
New Wuxi Life Science Holdings Ltd. 83,668,931 3.29%
China Universal Asset Management Co., Ltd. 70,436,627 2.77%
Boyu Capital Advisory Co. Ltd. 47,894,725 1.88%
Hillhouse Capital Management Ltd. (Invest) 43,524,934 1.71%
China Southern Asset Management Co., Ltd. 39,789,106 1.56%
Zhong Ou Asset Management Co., Ltd 39,772,582 1.56%
Hai Shan Zhou 38,724,998 1.52%
Holdings
NameEquities%Valuation
HYGEIA HEALTHCARE HOLDINGS CO., LIMITED (6078) 11,369,180 1.84% 84,852,852 USD
JW (CAYMAN) THERAPEUTICS CO. LTD (2126) 15,232,570 3.79% 29,194,591 USD
SENSORION (ALSEN) 5,249,608 6.58% 11,194,632 USD
UNITY BIOTECHNOLOGY, INC. (UBX) 1,477,987 2.68% 4,433,961 USD
Markets and indexes
- A-share
- SSE 50 /
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  603259.SH
- Datastream Code :  
Company contact information
WuXi AppTec Co., Ltd.
5 Bridge
CN-JS 214092 Wuxi

Phone : +86 (21) 5046-1111
Fax : +86 (21) 5046-1000
web site : https://www.wuxiapptec.com/
Brand Portfolio
In partnership withAllbrands.markets
More brands of WuXi AppTec Co., Ltd.
Sector Bio Therapeutic Drugs